Cargando…

Concomitant 5-aminosalicylic acid treatment does not affect 6-thioguanine nucleotide levels in patients with inflammatory bowel disease on thiopurines

BACKGROUND: There are conflicting data as to whether co-treatment with 5-aminosalicylic acid (5-ASA) in patients with inflammatory bowel disease (IBD) under azathioprine (AZA) or 6-mercaptopurine (6-MP) therapy may influence 6-thioguanine nucleotide (6-TGN) concentrations, and whether this combinati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Looser, Rahel, Doulberis, Michael, Rossel, Jean-Benoit, Franc, Yannick, Müller, Daniel, Biedermann, Luc, Rogler, Gerhard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hellenic Society of Gastroenterology 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10662061/ https://www.ncbi.nlm.nih.gov/pubmed/38023976 http://dx.doi.org/10.20524/aog.2023.0832

Ejemplares similares

Relationship Between Thiopurine S-Methyltransferase Genotype/Phenotype and 6-Thioguanine Nucleotide Levels in 316 Patients With Inflammatory Bowel Disease on 6-Thioguanine
por: Bayoumy, Ahmed B., et al.
Publicado: (2021)

Normal Ranges of Thiopurine Methyltransferase Activity Do Not Affect Thioguanine Nucleotide Concentrations With Azathioprine Therapy in Inflammatory Bowel Disease
por: Jonason, David E, et al.
Publicado: (2020)

Allopurinol and 5-aminosalicylic acid influence thiopurine-induced hepatotoxicity in vitro
por: Broekman, Mark M. T. J., et al.
Publicado: (2015)

Genotype–phenotype associations of polymorphisms within the gene locus of NOD-like receptor pyrin domain containing 3 in Swiss inflammatory bowel disease patients
por: Yoganathan, Priyatharsan, et al.
Publicado: (2021)

Thiopurine Methyltransferase Predicts the Extent of Cytotoxicty and DNA Damage in Astroglial Cells after Thioguanine Exposure
por: Hosni-Ahmed, Amira, et al.
Publicado: (2011)

Increments in DNA-thioguanine level during thiopurine-enhanced maintenance therapy of acute lymphoblastic leukemia
por: Larsen, Rikke Hebo, et al.
Publicado: (2021)

The presence of genetic risk variants within PTPN2 and PTPN22 is associated with intestinal microbiota alterations in Swiss IBD cohort patients
por: Yilmaz, Bahtiyar, et al.
Publicado: (2018)

Uveitis manifestations in patients of the Swiss Inflammatory Bowel Disease Cohort Study
por: Biedermann, Luc, et al.
Publicado: (2019)

Effect of distance to specialist care for the diagnosis and disease outcome of inflammatory bowel disease in the Swiss inflammatory bowel disease cohort study
por: Grob, Lorenz, et al.
Publicado: (2020)

Excited-State Dynamics of the Thiopurine Prodrug 6-Thioguanine: Can N9-Glycosylation Affect Its Phototoxic Activity?
por: Ashwood, Brennan, et al.
Publicado: (2017)

Thiopurine Methyltransferase Activity and Thiopurine Metabolites in Inflammatory Bowel Disease
por: El-Matary, Wael
Publicado: (2020)

Thiopurines in Inflammatory Bowel Disease. How to Optimize Thiopurines in the Biologic Era?
por: Gargallo-Puyuelo, Carla J., et al.
Publicado: (2021)

Genetic risk factors predict disease progression in Crohn’s disease patients of the Swiss inflammatory bowel disease cohort
por: Ditrich, Felicitas, et al.
Publicado: (2020)

Association between 6-thioguanine nucleotide levels and preventing production of antibodies to infliximab in patients with inflammatory bowel disease
por: Phillips, Jennifer, et al.
Publicado: (2023)

Utility of Maternal 6-Thioguanine Nucleotide Levels in Predicting Neonatal Pancytopenia
por: Maruyama, Hidehiko, et al.
Publicado: (2012)

Quantification of Thioguanine in DNA Using Liquid Chromatography-Tandem Mass Spectrometry for Routine Thiopurine Drug Monitoring in Patients With Pediatric Acute Lymphoblastic Leukemia
por: Choi, Rihwa, et al.
Publicado: (2021)

Thiopurine methyltransferase genotype and thiopurine S-methyltransferase activity in Greek children with inflammatory bowel disease
por: Gazouli, Μaria, et al.
Publicado: (2012)

Nucleoside diphosphate-linked moiety X-type motif 15 R139C genotypes impact 6-thioguanine nucleotide cut-off levels to predict thiopurine-induced leukopenia in Crohn’s disease patients
por: Zhu, Xia, et al.
Publicado: (2019)

Efficacy of thioguanine treatment in inflammatory bowel disease: A systematic review
por: Meijer, Berrie, et al.
Publicado: (2016)

Exposure to Thioguanine During 117 Pregnancies in Women With Inflammatory Bowel Disease
por: Crouwel, Femke, et al.
Publicado: (2022)

Risk factors for gallstones and kidney stones in a cohort of patients with inflammatory bowel diseases
por: Fagagnini, Stefania, et al.
Publicado: (2017)

Genotype-Phenotype Associations of the CD-Associated Single Nucleotide Polymorphism within the Gene Locus Encoding Protein Tyrosine Phosphatase Non-Receptor Type 22 in Patients of the Swiss IBD Cohort
por: Spalinger, Marianne R., et al.
Publicado: (2016)

Widely differing screening and treatment practice for osteoporosis in patients with inflammatory bowel diseases in the Swiss IBD cohort study
por: Schüle, Solvey, et al.
Publicado: (2017)

Use of thiopurines in inflammatory bowel disease: an update
por: Singh, Arshdeep, et al.
Publicado: (2022)

Effects of anti-TNF therapy and immunomodulators on anxiety and depressive symptoms in patients with inflammatory bowel disease: a 5-year analysis
por: Siebenhüner, Alexander R., et al.
Publicado: (2021)

Cytotoxicity of Thiopurine Drugs in Patients with Inflammatory Bowel Disease
por: Zakerska-Banaszak, Oliwia, et al.
Publicado: (2022)

Measurements of 6-thioguanine nucleotide levels with TPMT and NUDT15 genotyping in patients with Crohn’s disease
por: Lee, Ji Hyeon, et al.
Publicado: (2017)

Genotype-Guided Thiopurine Dosing Does not Lead to Additional Costs in Patients With Inflammatory Bowel Disease
por: Sluiter, Reinier L, et al.
Publicado: (2019)

Abdominal pain in patients with inflammatory bowel disease: association with single-nucleotide polymorphisms prevalent in irritable bowel syndrome and clinical management
por: Ledergerber, Martina, et al.
Publicado: (2021)

Safety of Thioguanine in Pediatric Inflammatory Bowel Disease: A Multi-Center Case Series
por: Bayoumy, Ahmed B., et al.
Publicado: (2022)

Safety and Efficacy of Split-Dose Thiopurine vs Low-Dose Thiopurine-Allopurinol Cotherapy in Pediatric Inflammatory Bowel Disease
por: Cococcioni, Lucia, et al.
Publicado: (2022)

Thiopurine metabolite level and toxicity in Indians with inflammatory bowel disease
por: Parkar, Suruchi P, et al.
Publicado: (2017)

Biomarkers Predictive of Response to Thiopurine Therapy in Inflammatory Bowel Disease
por: Cornish, Jack S., et al.
Publicado: (2020)

Thiopurines: Recent Topics and Their Role in the Treatment of Inflammatory Bowel Diseases
por: Tominaga, Keiichi, et al.
Publicado: (2021)

Thioguanine is Effective as Maintenance Therapy for Inflammatory Bowel Disease: A Prospective Multicentre Registry Study
por: Simsek, Melek, et al.
Publicado: (2023)

Pharmacogenetics of thiopurine therapy: from thiopurine S-methyltransferase to S-adenosylmethionine
por: Mlinarič-Raščan, Irena, et al.
Publicado: (2009)

The appearance of joint manifestations in the Swiss inflammatory bowel disease cohort
por: Hiller, Aimee, et al.
Publicado: (2019)

Lifestyle factors associated with inflammatory bowel disease: data from the Swiss IBD cohort study
por: Lautenschlager, Severin A., et al.
Publicado: (2023)

Quantification of Thiopurine Nucleotides in Erythrocytes and Clinical Application to Pediatric Acute Lymphoblastic Leukemia
por: Moon, Soo Young, et al.
Publicado: (2019)

DNA-thioguanine nucleotide as a treatment marker in acute lymphoblastic leukemia patients with NUDT15 variant genotypes
por: Ju, Hee Young, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_50sp94prvg97p338uqb3a250sl